Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: TPL BK Pacers

Again thank you, BaNosser for providing us with all these informations.

Here is in an interesting part from the Disclosure Statement - I highlighted the most important sentence:

"TPL’s revenues have stagnated since the filing of the Chapter 11 Petition and were on a downward projector since 2010 ($10.1million in 2012, $11.3 million in 2011 and $17.6 million in 2010); however, TPL believes that the emergance from Bankruptcy, new management and the additions of a second licensing agent for MMP Portfolion will be the impetus for revenues to increase significantly, and return to pre- 2009 levels as several of the litigations reach pivotal points.
TPL believes that the recent stagnation is due largely to a “wait-and-see” approach being adopted by infringers who are waiting to see if TPL emerges from Chapter 11.
TPL and the Committee have worked diligently together to negotiate and file the joint Plan and this Disclosure Statement.
TPL believes that the negative impact to revenue of not having a confirmed Plan will continue until a Plan has been confirmed and an Effective Date set.
"

Share
New Message
Please login to post a reply